This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2006 Nov 4;368(9547):1570-1; author reply 1571.

doi: 10.1016/S0140-6736(06)69653-0.

How clean was the KLEAN trial?

PMID: 17084747
DOI: 10.1016/S0140-6736(06)69653-0

Comment

How clean was the KLEAN trial?

Paul Bellman. Lancet. 2006.

. 2006 Nov 4;368(9547):1570-1; author reply 1571.

doi: 10.1016/S0140-6736(06)69653-0.

Author

PMID: 17084747
DOI: 10.1016/S0140-6736(06)69653-0

No abstract available

PubMed Disclaimer

Comment on

The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial.
Eron J Jr, Yeni P, Gathe J Jr, Estrada V, DeJesus E, Staszewski S, Lackey P, Katlama C, Young B, Yau L, Sutherland-Phillips D, Wannamaker P, Vavro C, Patel L, Yeo J, Shaefer M; KLEAN study team. Eron J Jr, et al. Lancet. 2006 Aug 5;368(9534):476-82. doi: 10.1016/S0140-6736(06)69155-1. Lancet. 2006. PMID: 16890834 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information